DE60012713D1 - Durch xanthurensäure modifizierte proteine - Google Patents

Durch xanthurensäure modifizierte proteine

Info

Publication number
DE60012713D1
DE60012713D1 DE60012713T DE60012713T DE60012713D1 DE 60012713 D1 DE60012713 D1 DE 60012713D1 DE 60012713 T DE60012713 T DE 60012713T DE 60012713 T DE60012713 T DE 60012713T DE 60012713 D1 DE60012713 D1 DE 60012713D1
Authority
DE
Germany
Prior art keywords
proteins modified
xanthuric
acid
xanthuric acid
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60012713T
Other languages
English (en)
Other versions
DE60012713T2 (de
Inventor
Halina Malina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60012713D1 publication Critical patent/DE60012713D1/de
Publication of DE60012713T2 publication Critical patent/DE60012713T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
DE2000612713 1999-03-26 2000-03-23 Durch xanthurensäure modifizierte proteine Expired - Lifetime DE60012713T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9903791A FR2791263B1 (fr) 1999-03-26 1999-03-26 Preparations des medicaments bases sur une reponse immunitaire contre l'accumulation de proteines modifiees par l'acide xanthurenique
FR9903791 1999-03-26
PCT/FR2000/000757 WO2000058344A1 (fr) 1999-03-26 2000-03-23 Proteines modifiees par l'acide xanthurenique

Publications (2)

Publication Number Publication Date
DE60012713D1 true DE60012713D1 (de) 2004-09-09
DE60012713T2 DE60012713T2 (de) 2005-12-01

Family

ID=9543676

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2000612713 Expired - Lifetime DE60012713T2 (de) 1999-03-26 2000-03-23 Durch xanthurensäure modifizierte proteine

Country Status (4)

Country Link
EP (1) EP1165600B1 (de)
DE (1) DE60012713T2 (de)
FR (1) FR2791263B1 (de)
WO (1) WO2000058344A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613505B2 (en) 2001-04-12 2003-09-02 Bioresource International, Inc. Composition and method for destruction of infetious prion proteins
FR2827599A1 (fr) * 2001-07-20 2003-01-24 Neuro3D Composes derives de quinoleine et quinoxaline,preparation et utilisations
AU2002950217A0 (en) 2002-07-16 2002-09-12 Prana Biotechnology Limited 8- Hydroxy Quinoline Derivatives
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
FR2864535B1 (fr) * 2003-12-24 2006-12-22 Merck Sante Sas Derives acides de quinoline et leurs applications en therapeutique
JP5486808B2 (ja) 2005-11-30 2014-05-07 アッヴィ・インコーポレイテッド アミロイドベータタンパク質に対するモノクローナル抗体及びその使用
PL1954718T3 (pl) 2005-11-30 2015-04-30 Abbvie Inc Przeciwciała skierowane przeciwko A globulomerowi, ich reszty wiążące antygeny, odpowiednie hybrydomy, kwasy nukleinowe, wektory, komórki gospodarze, sposoby wytwarzania tych przeciwciał, kompozycje zawierające te przeciwciała, zastosowania tych przeciwciał i sposoby stosowania tych przeciwciał
FR2901479B1 (fr) * 2006-05-24 2009-09-04 Halina Zofia Malina Reponse immunitaire contre les peptides modifies de facon covalente qui modifient d'interactions de phosphatidylinositol phosphates et calmoduline dans un organisme vivant
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US20100311767A1 (en) 2007-02-27 2010-12-09 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
FR2922769A1 (fr) * 2007-10-31 2009-05-01 Halina Malina Modification des sequences intrinsequement desordonnees pour la preparation de vaccins
CN104744591B (zh) 2010-04-15 2022-09-27 Abbvie德国有限责任两合公司 β淀粉样蛋白结合蛋白
CN105348387B (zh) 2010-08-14 2020-08-25 Abbvie 公司 β淀粉样蛋白结合蛋白

Also Published As

Publication number Publication date
DE60012713T2 (de) 2005-12-01
EP1165600A1 (de) 2002-01-02
FR2791263A1 (fr) 2000-09-29
FR2791263B1 (fr) 2001-04-27
EP1165600B1 (de) 2004-08-04
WO2000058344A1 (fr) 2000-10-05

Similar Documents

Publication Publication Date Title
EE04772B1 (et) 3-arüül-2-hüdroksüpropaanhappe derivaat (I)
ATE269861T1 (de) Substituierte indolalkansäure
ATE239005T1 (de) (4-sulfonylamino)-tetrahydropyran-4-carbonsäure hydroxamiden
DK1221955T3 (da) Immunstimulerende nukleinsyre
IS2231B (is) Nýjar amínóprópýlfosfínsýrur
ATE248812T1 (de) Arylsulfonylhydroxamsäurederivate
DK1003720T3 (da) Aryloxyarylsulfonylaminohydroxamsyrederivater
IS6367A (is) Interferon-gamma tengiprótín
DE50212761D1 (de) Neuartige aminodicarbonsäurederivate
DK1100769T3 (da) Aminomethylcarboxylsyrederivater
ID29621A (id) ASETILENIK α-AMINO ASAM HIDROKSAMAT SULFONAMIDA BERBASIS ASAM PENGHAMBAT-PENGHAMBAT TACE
ATE419231T1 (de) Mono-substituierte 3-propyl-gamma- aminobuttersäure
EE200000717A (et) Uus 3-arüül-2-hüdroksüpropaanhappe derivaat III
TR199802289A3 (tr) Fosfonasit-ikame etmis benzazepinon-n-asetikasit türevleri.
DE60012713D1 (de) Durch xanthurensäure modifizierte proteine
EE200100708A (et) Asendatud fenoksüäädikhapped
DE50005284D1 (de) Substituierte n-benzyl-indol-3-yl- glyoxylsäure-derivate mit antitumorwirkung
ID26379A (id) Katalis asam padat
ATE309220T1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2- carbonsäurederivate
ATE309983T1 (de) Beta-thio-aminosäuren
NO20021275L (no) Transgentproduserte fusjonsproteiner
DE10082298D2 (de) Chimäre Proteine
EE200000239A (et) Uued metüleenbisfosfoonhappe derivaadid
ATE278712T1 (de) Antikörper gegen plazentaprotein 13
DE60117001D1 (de) Nectin-3 proteine

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication of lapse of patent is to be deleted